Wellington Shields & Co., LLC Kodiak Sciences Inc. Transaction History

Wellington Shields & Co., LLC

  • $303 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$1.8 - $7.49 $70,200 - $292,110
-39,000 Reduced 32.77%
80,000 $144,000
Q2 2023

Aug 11, 2023
BUY
$4.3 - $9.48 $172,000 - $379,200
40,000 Added 50.63%
119,000 $821,000
Q3 2022

Nov 14, 2022
BUY
$7.57 - $12.5 $598,030 - $987,500
79,000 New
79,000 $611,000

Others Institutions Holding KOD

# of Institutions
104
Shares Held
39.8M
Call Options Held
7.6K
Put Options Held
3.5K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $138M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email